Module contents

Module home
Module introduction
Module information
About the author

Learning notes

Pre-module test

 

Section 1: Treatment of antidepressant-induced sexual dysfunction

(1.1) Section 1: Treatment of antidepressant-induced sexual dysfunction

(1.2) Before you begin

(1.3) Clinical vignette: a woman who thought she was 'frigid'

(1.4) Comment: a woman who thought she was 'frigid'

(1.5) Reflection

(1.6) Suggested answers

(1.7) Reflection

(1.8) Suggested answers

(1.9) Interactive exercises: treatment strategies

(1.10) Reflection

(1.11) Pharmacological reversal: target noradrenaline

(1.12) Interactive exercise: outlook: autoreceptors

(1.13) Reflection

(1.14) Pharmacological reversal: target serotonin

(1.15) Reflection

(1.16) Pharmacological reversal: target dopamine

(1.17) Reflection

(1.18) Pharmacological reversal: other targets

(1.19) Pharmacological reversal: target nitric oxide (NO)

(1.20) Phosphodiesterase5 (PD5)-inhibitors head to head

(1.21) Phosphodiesterase5 (PD5)-inhibitors

(1.22) It all starts with nitric oxide…

(1.23) PD5-inhibitors: contraindications and warnings - what your patient should know

(1.24) Yet another story...

(1.25) Alprostadil

(1.26) Female sexual dysfunctions: licensed pharmacological treatments

(1.27) Female sexual dysfuction: drugs that remain controversial

(1.28) Section 1: Recap

(1.29) Section 1: Summary

 

Section 2: Other treatments for sexual dysfunction

(2.1) Section 2: Other treatments for sexual dysfunction

(2.2) Reflection

(2.3) Suggested answers

(2.4) Hormone treatments for women

(2.5) Why has HRT fallen out of favour with women?

(2.6) HRT: what does it mean for the individual patient?

(2.7) Hormone treatments for women - potential adverse effects

(2.8) Reflection

(2.9) Suggested answers

(2.10) Hormone treatments for men

(2.11) Outlook

(2.12) Reflection

(2.13) Suggested answers

(2.14) Complementary medicines for sexual dysfunction

(2.15) Recommending complementary medicines: issues

(2.16) Hypomanic episodes

(2.17) Outlook

(2.18) Section 2: Recap

(2.19) Section 2: Summary

 

Section 3: Formal aspects of prescribing for sexual dysfunction

(3.1) Section 3: Formal aspects of prescribing for sexual dysfunction

(3.2) Prescribing unlicensed medications: recommendations

(3.3) The GMC requirements for prescribing unlicensed medications

(3.4) Informed consent

(3.5) The criteria for informed consent: quick recap

(3.6) Reimbursement for treatments

(3.7) The BNF requirements for prescribing for erectile dysfunction

(3.8) The severe distress clause

(3.9) Section 3: Recap

(3.10) Section 3: Summary

 

Module summary

Module test

Acknowledgements

Send feedback

 

Useful resources

Take-home notes

References

Further reading

© 2019 Royal College of Psychiatrists